Andrew Dold
Orthopaedic Surgery · Frisco, TXNPI 1932576980
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Smith+Nephew at 38.7% of the total. Reporting peaked in 2019 at $26,515 and has fallen 83.6% since, to $4,357 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $268.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$41K
- Terumo BCT, Inc.$13K
- Medical Device Business Services, Inc.$12K
- Amgen$8K
- Depuy Synthes Products, Inc.$7K
- Pacira Pharmaceuticals Incorporated$6K
- plus $18K from 31 others
Across 2 payments — averaging $16,130 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$32K
What the payments were for
- Consulting fees$54,32651%
- Speaking & faculty fees$15,58815%
- Travel & lodging$17,23916%
- Food & beverage$16,13815%
- Education$3,7103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 121 | $41,424 |
| Terumo BCT, Inc. | 4 | $13,286 |
| Medical Device Business Services, Inc. | 27 | $12,496 |
| Amgen | 40 | $8,180 |
| Depuy Synthes Products, Inc. | 3 | $7,369 |
| Pacira Pharmaceuticals Incorporated | 5 | $6,261 |
| Stryker | 63 | $4,464 |
| Zimmer Biomet | 24 | $4,160 |
| Linvatec Corporation | 3 | $2,451 |
| Pylant Medical | 11 | $2,439 |
| Johnson & Johnson(2 entities) | 31 | $1,455 |
| Vericel Corporation | 19 | $1,073 |
| Microport Orthopedics Inc | 6 | $747 |
| Ferring Pharmaceuticals Inc. | 6 | $139 |
| Kowa Pharmaceuticals America, Inc. | 2 | $127 |
| Orthalign Inc | 1 | $110 |
| RTI Surgical, Inc | 1 | $96 |
| Orthofix Medical, Inc. | 9 | $91 |
| Bioventus LLC | 2 | $65 |
| Innovation Technologies Inc | 2 | $52 |
| Highridge Medical LLC | 2 | $52 |
| Cumberland Pharmaceuticals, Inc. | 2 | $52 |
| Globus Medical | 1 | $43 |
| Boston Scientific | 1 | $41 |
| Moximed, Inc | 1 | $32 |
| EBI, LLC | 1 | $32 |
| Henry Schein, Inc. | 1 | $32 |
| Flower Orthopedics Coporation | 1 | $31 |
| Precision Medical Products, Inc. | 1 | $30 |
| Solventum Corporation | 1 | $26 |
| ERMI LLC | 1 | $25 |
| Medtronic | 1 | $25 |
| Lazurite Inc. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Baxter Healthcare | 1 | $17 |
| Avanos Medical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HEALIX$16,542
- SPATIAL FRAME$14,174
- HARVEST BMAC$10,500
- ULTRABUTTON$8,563
- Bone Anchors with Arthroscopic Delivery System$8,543
- NOVOSTITCH$7,883
- PENNSAID$7,143
- Healicoil$6,718
- EXPAREL$6,200
- Acufex$4,842
- Biosure$4,563
- BIOSURE REGENESORB$4,135
- Xtendobutton$4,000
- TRUNAV$4,000
- ENDOBUTTON CL ULTRA$4,000
- Bone Marrow Aspirate Concentrate System$2,786
- Q-FIX Hip$2,636
- Hipstruments$2,502
- BioBrace 23mm$2,402
- Bioinductive Implant with Arthroscopic Delivery System - Medium$2,238
How this compares
$107,001 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 61 | $2,197 |
| Ondansetron OdtOndansetron | 48 | $639 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $610 |
| Meloxicam | 108 | $364 |
| Tramadol Hcl | 56 | $145 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $105 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Frisco
- Justin KaneFrisco$263K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.